PARP1 and cholangiocarcinoma: (113) revealed that low doses of PARP1 inhibitors increased the radiosensitivity of cholangiocarcinoma cells and suggested that the radiation-induced increase in PAR can also predict radiosensitization by PARP1 inhibitors.